- 16
- 0
- 约1.4万字
- 约 4页
- 2017-05-12 发布于天津
- 举报
疏风解毒胶囊联合消银颗粒治疗寻常型银屑病(血热证)的临.PDF
·714 · 现代药物与临床 Drugs Clinic 第 32 卷 第 4 期 2017 年 4 月
疏风解毒胶囊联合消银颗粒治疗寻常型银屑病(血热证)的临床研究
尚静雯,杜春伟
周口市中心医院 皮肤科,河南 周口 466000
摘 要:目的 观察疏风解毒胶囊联合消银颗粒治疗寻常型银屑病(血热证)的临床疗效。方法 选取 2013 年 6 月—2015
年 6 月来周口市中心医院皮肤科就诊的寻常型银屑病患者 98 例,按就诊时间分为对照组(46 例)和治疗组(52 例)。对照
组口服消银颗粒,1 袋/次,3 次/d 。治疗组在对照组治疗基础上口服疏风解毒胶囊,4 粒/次,3 次/d 。两组均连续治疗 2 个
月。观察两组的临床疗效,比较两组治疗前后肿瘤坏死因子 α (TNF-α)、白细胞介素 4 (IL-4 )、白细胞介素 17 (IL-17 )、
银屑病皮损面积严重指数(PASI )评分的变化情况。结果 治疗后,对照组和治疗组的总有效率分别为 67.4%、84.6%,两
组比较差异具有统计学意义(P <0.05)。治疗后,两组患者TNF-α、IL-4 、IL-17 、PASI 评分均较治疗前显著降低,同组治疗前
后差异有统计学意义(P <0.05);治疗后,治疗组TNF-α、IL-4、IL-17 、PASI 评分低于对照组,两组比较差异具有统计学意义
(P <0.05)。结论 疏风解毒胶囊联合消银颗粒治疗寻常型银屑病(血热证)具有较好的临床疗效,可降低 PASI 评分和相关
因子水平,具有一定的临床推广应用价值。
关键词:疏风解毒胶囊;消银颗粒;寻常型银屑病;血热证;银屑病皮损面积严重指数评分
中图分类号:R986 文献标志码:A 文章编号:1674 - 5515(2017)04 - 0714 - 04
DOI: 10.7501/j.issn.1674-5515.2017.04.038
Clinical study on Shufeng Jiedu Capsules compared with Xiaoyin Granules in
treatment of psoriasis vulgaris (blood-heat syndrome)
SHANG Jing-wen, DU Chun-wei
Department of Dermatology, Zhoukou Central Hospital, Zhoukou 466000, China
Abstract: Objective To observe the efficacy of Shufeng Jiedu Capsules compared with Xiaoyin Granules in treatment of psoriasis
vulgaris (blood-heat syndrome). Methods Patients (98 cases) with psoriasis vulgaris in Zhoukou Central Hospital from June 2013 to
June 2015 were divided into control (46 cases) and treatment (52 cases) groups according to the clinic time. Patients in the control
group werepo administered with Xiaoyin Granules, 1 bag/time, three times daily. Patients in the treatment group were po administered
with Shufeng Jiedu Capsules on the basis of the control group, 4 grains/time, three times daily. Patients in two groups were treated for
two months. After treatment, the clinical efficacy was evaluated, and the changes of TNF-α, IL-4, IL-17, and PASI scores before
原创力文档

文档评论(0)